MindMed Stock Skyrockets 94% Year to Date: What's Driving It? [Yahoo! Finance]
Castle Biosciences, Inc. - Common stock (CSTL)
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
form of lysergide D-tartrate (LSD), for the treatment of generalized anxiety disorder (GAD) and major depressive disorder (MDD). 2024 Turns Out to Be a Transformational Year for MindMed 2024 was a transformational year for the company when it executed many important milestones, one of which was initiating the 52-week Voyage phase III study on MM120 ODT in GAD earlier this month. Top-line data from a 12-week study is anticipated in the first half of 2026. In the year, MindMed also raised approximately $250 million through two equity financings. The company also obtained a newly issued patent covering MM120 ODT and extended intellectual property protection through 2041. All these factors have led MindMed's stock to rise 93.5% year to date against a decrease of 13.7% for the industry. Zacks Investment Research Image Source: Zacks Investment Research MNMD's MM120 ODT Can be a Novel Option for GAD & MDD Earlier this year, MindMed presented impressive data from the phase IIb
Show less
Read more
Impact Snapshot
Event Time:
CSTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSTL alerts
High impacting Castle Biosciences, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CSTL
News
- Castle Biosciences reports preliminary data from atopic dermatitis test study [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile TestBusiness Wire
- Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- 4 Solid Net Profit Margin Stocks to Boost Portfolio Returns [Yahoo! Finance]Yahoo! Finance
CSTL
Earnings
- 11/4/24 - Beat
CSTL
Sec Filings
- 12/19/24 - Form 4
- 12/17/24 - Form 4
- 12/13/24 - Form 144
- CSTL's page on the SEC website